Search

Ludivine C Moine

from Cambridge, MA
Age ~42
Get Report
Also known as:
Ludivine Riber
Phone and address:
15 York Pl UNIT 4, Cambridge, MA 02141
Related to:
Gregory Moine
Connected to:
Afshin Moini, 66Douglas H Moini, 56Saeid Moini, 70Shapour Moinian, 69Jay F Moinicken, 62Melissa Moinicken, 53Iffat M Moinuddin, 42Jameela Moinuddin, 64Mohammad Moinuddin, 60Riaz K Moinuddin, 60

Ludivine Moine Phones & Addresses

  • 15 York Pl UNIT 4, Cambridge, MA 02141
  • Uncasville, CT
  • Niantic, CT
  • Troy, MI
  • Minneapolis, MN
  • 171 Massapeag Rd, Uncasville, CT 06382

Resumes

Resumes

Ludivine Moine Photo 1

Senior Scientist Chez Pgrd

View page
Position:
Senior Associate scientist at Pfizer Pharmaceuticals, Senior Associate scientist at Pfizer
Location:
Région de New London/Norwich, Connecticut, États-Unis
Industry:
Pharmaceuticals
Work:
Pfizer Pharmaceuticals
Senior Associate scientist
Pfizer
Senior Associate scientist
GlaxoSmithKline 2004 - 2005
year trainee
Ludivine Moine Photo 2

Ludivine Moine

View page

Publications

Us Patents

Stability-Modulating Linkers For Use With Antibody Drug Conjugates

View page
US Patent:
20210205463, Jul 8, 2021
Filed:
Feb 23, 2021
Appl. No.:
17/183265
Inventors:
- New York NY, US
Magdalena Grazyna DORYWALSKA - Redwood City CA, US
Ludivine MOINE - Uncasville CT, US
Assignee:
PFIZER INC. - New York NY
RINAT NEUROSCIENCE CORP. - New York NY
International Classification:
A61K 47/65
A61K 47/64
A61K 47/68
Abstract:
The present invention provides stability-modulated antibody-drug conjugates, stability-modulating linker components used to make these stability-modulated antibody-drug conjugates, therapeutic methods using stability-modulated antibody-drug conjugates, and methods of making stability modulating linkers and stability-modulated antibody-drug conjugates.

Modulators Of Methyl Modifying Enzymes, Compositions And Uses Thereof

View page
US Patent:
20210206776, Jul 8, 2021
Filed:
May 17, 2019
Appl. No.:
17/057225
Inventors:
- Cambridge MA, US
Avinash Khanna - Cambridge MA, US
Ludivine Moine - Cambridge MA, US
International Classification:
C07D 491/056
A61P 35/00
Abstract:
Provided are novel compounds of Formula (I): Formula (I); and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with methyl modifying enzymes. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with methyl modifying enzymes.

Modulators Of Methyl Modifying Enzymes, Compositions And Uses Thereof

View page
US Patent:
20200317651, Oct 8, 2020
Filed:
Apr 23, 2020
Appl. No.:
16/856454
Inventors:
- Cambridge MA, US
Victor S. Gehling - Somerville MA, US
Avinash Khanna - Cambridge MA, US
Ludivine Moine - Cambridge MA, US
Jacob I. Stuckey - Framingham MA, US
International Classification:
C07D 405/14
A61P 35/00
C07D 405/12
Abstract:
Provided are novel compounds of Formula (I):and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with methyl modifying enzymes. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with methyl modifying enzymes.

Modulators Of Methyl Modifying Enzymes, Compositions And Uses Thereof

View page
US Patent:
20190322651, Oct 24, 2019
Filed:
Apr 18, 2019
Appl. No.:
16/387851
Inventors:
- Cambridge MA, US
Victor S. Gehling - Somerville MA, US
Avinash Khanna - Cambridge MA, US
Ludivine Moine - Cambridge MA, US
Jacob I. Stuckey - Framingham MA, US
International Classification:
C07D 405/14
C07D 405/12
A61P 35/00
Abstract:
Provided are novel compounds of Formula (I):and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with methyl modifying enzymes. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with methyl modifying enzymes.

Stability-Modulating Linkers For Use With Antibody Drug Conjugates

View page
US Patent:
20180140714, May 24, 2018
Filed:
Aug 14, 2015
Appl. No.:
15/504801
Inventors:
- New York NY, US
- South San Francisco CA, US
Magdalena Grazyna DORYWALSKA - Redwood City CA, US
Ludivine MOINE - Uncasville CT, US
Assignee:
PFIZER INC. - New York NY
RINAT NEUROSCIENCE CORP. - South San Francisco CA
International Classification:
A61K 47/65
A61K 47/68
A61K 47/64
Abstract:
The present invention provides stability-modulated antibody-drug conjugates, stability-modulating linker components used to make these stability-modulated antibody-drug conjugates, therapeutic methods using stability-modulated antibody-drug conjugates, and methods of making stability modulating linkers and stability-modulated antibody-drug conjugates.
Control profile
Ludivine C Moine from Cambridge, MA, age ~42 Get Report